SYNERGISTIC EFFICACY OF Y BOX BINDING PROTEIN 1 (YBX1) INHIBITION COMBINED WITH CHEMOTHERAPY FOR THE TREATMENT OF MYC-AMPLIFIED MEDULLOBLASTOMA

被引：0
|
作者：
Carney, Stephen [1 ]
Bonatto, Christian [2 ]
Guadarrama, Guadalupe [3 ]
Tailor, Dhanir [4 ]
Malhotra, Sanjay [4 ]
Evans, Myron, II [1 ]
机构：
[1] Seattle Childrens Res Inst, Seattle, WA USA
[2] Allen Brain Inst, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-32
引用
收藏
页数：1
相关论文
共 32 条
  • [21] Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle
    Yu, Ying-Nan
    Yip, George Wai-Cheong
    Tan, Puay-Hoon
    Thike, Aye Aye
    Matsumoto, Ken
    Tsujimoto, Masafumi
    Bay, Boon-Huat
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (02) : 483 - 492
  • [22] Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity
    Madeleine Saupe
    Lisa Rauschenberger
    Melanie Preuß
    Stefan Oswald
    Sebastian Fussek
    Uwe Zimmermann
    Reinhard Walther
    Cornelius Knabbe
    Martin Burchardt
    Matthias B. Stope
    World Journal of Urology, 2015, 33 : 1481 - 1486
  • [23] Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity
    Saupe, Madeleine
    Rauschenberger, Lisa
    Preuss, Melanie
    Oswald, Stefan
    Fussek, Sebastian
    Zimmermann, Uwe
    Walther, Reinhard
    Knabbe, Cornelius
    Burchardt, Martin
    Stope, Matthias B.
    WORLD JOURNAL OF UROLOGY, 2015, 33 (10) : 1481 - 1486
  • [24] HPV type 16 and 18 E7 protein disrupt direct interaction of pluripotent protein CTCF with Y box binding protein 1 (YB-1) and up-regulates c-myc gene
    Balakrishnan, V.
    Othman, N. H.
    Shamsuddin, S.
    FEBS JOURNAL, 2008, 275 : 440 - 440
  • [25] Inhibition of pro-collagen I expression by oxymatrine in hepatic stellate cells is mediated via nuclear translocation of Y-box binding protein 1
    Du, Meiling
    Zhang, Jun
    Xu, Diannan
    Li, Wenshuai
    Liu, Jie
    Liu, Fei
    MOLECULAR MEDICINE REPORTS, 2015, 12 (06) : 8101 - 8106
  • [26] Prolonged Survival of Mice in an Orthotopic Glioblastoma Stem Cell Mouse Model after Treatment with an Y-Box Binding Protein 1 (YB-1) Dependent Oncolytic Adenovirus
    Mantwill, Klaus
    Naumann, Ulrike
    Seznec, Janina
    Girbinger, Vroni
    Beier, Dagmar
    Lage, Hermann
    Surowiak, Pawel
    Mittelbronn, Michel
    Schlegel, Juergen
    Holm, Per S.
    MOLECULAR THERAPY, 2012, 20 : S84 - S84
  • [27] Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase
    Gao, Yuanyuan
    Fotovati, Abbas
    Lee, Cathy
    Wang, Michelle
    Cote, Gilbert
    Guns, Emma
    Toyota, Brian
    Faury, Damien
    Jabado, Nada
    Dunn, Sandra E.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12) : 3276 - 3284
  • [28] The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro
    Stope, M. B.
    Weiss, M.
    Popp, S. L.
    Joffroy, C.
    Buck, M. B.
    Mustea, A.
    Brucker, S.
    Wallwiener, D.
    Knabbe, C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (01) : 16 - 18
  • [29] Y-Box binding protein YB-1 identifies high-risk primary breast cancer patients benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy
    Schmitt, Manfred
    Gluz, Oleg
    Mengele, Karin
    Nitz, Ulrike
    Royer, Hans-Dieter
    Harbeck, Nadia
    CANCER RESEARCH, 2009, 69
  • [30] Y-Box-Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy
    Gluz, Oleg
    Mengele, Karin
    Schmitt, Manfred
    Kates, Ronald
    Diallo-Danebrock, Raihana
    Neff, Frauke
    Royer, Hans-Dieter
    Eckstein, Niels
    Mohrmann, Svjetlana
    Ting, Evelyn
    Kiechle, Marion
    Poremba, Christopher
    Nitz, Ulrike
    Harbeck, Nadia
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6144 - 6151
1234